Effect of Prone Positioning on Mortality in Patients With Severe and Persistent Acute Respiratory Distress Syndrome (Proseva)

December 13, 2025 updated by: Hospices Civils de Lyon
We project to test the effect of prone position on mortality in severe ARDS patients (PaO2/FiO2<150 with FiO2 > or = 0.6 and positive end-expiratory pressure > or = 5 cmH2O). Ventilator will be set in accordance with current standards aiming at protecting the lungs from VALI. Patients will be randomized into two arms: prone group in which proning will be realized for at least 16 hours a day and supine group in which patients will stay in a semi-recumbent position. Primary end-point is 28-day mortality of all causes. Secondary end-points are 90-day mortality of all causes and incidence of ventilator-acquired pneumonia. Study sample was calculated to detect ability of proning to reduce mortality from 60 to 45% percent, at one-tailed alpha error of 5% and power of 90% and 230 patients are needed in each arm.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The acute respiratory distress syndrome (ARDS) is an acute respiratory failure characterized by bilateral pulmonary infiltrates on frontal chest radiography, arterial oxygen tension (Pao2) to fraction of inspired oxygen (FiO2) ratio of 200 or less, and absence of evidence for left atrial hypertension. In-hospital mortality remains high: from 40 to 60%. Typical pathological findings include disruption of the alveolar epithelium, diffuse alveolar damage, hyaline membranes and pulmonary inflammation. Gas exchange is severely altered making of invasive mechanical ventilation required in most of the cases. Mechanical ventilation should be judiciously set in order to protect the lung from ventilator- associated lung injury (VALI). VALI is commonly seen as the expression of two main alveolar strains. The well documented one to date is over distension of alveoli when high tidal volumes are used. A North-American randomized controlled trial (RCT) has demonstrated that using low tidal volumes (6 ml per kilo of predicted weight) results in a 22% decrease in mortality when compared with high tidal volumes (12 ml per kilo of predicted weight). As suggested by an ancillary study of this trial, a reduced pulmonary inflammation is one of the contributing factors of this result. Therefore, minimizing VALI is a primary therapeutic goal. Low lung volume VALI is the second potential mechanism, though less well documented. It is expected to result from repetitive collapse and reopening of terminal respiratory units. Experimental data suggest that proning can reduce VALI by homogenizing lung strains. In ARDS patients, proning is mainly used due to its ability to improve gas exchange in 60 to 70% of patients. Nonetheless, 3 RCTs failed to demonstrate a significant effect on mortality of proning in three clinical situations: 1: acute lung injury, 2: hypoxemic acute respiratory failure, 3: ARDS. Post hoc analysis of one of them has suggested an effect of proning on mortality for the most hypoxemic sub-group. Studies limitations can explain lack of statistical significance as lack of power, heterogeneity of patients, insufficient duration of proning, high tidal volumes. Only one RCT was specifically designed for ARDS. Mortality was 25% lowest in the prone position arm, but this difference was not significant due to lack of power. So, the capability of proning to improve patient survival in ARDS is still an open question.

Study Type

Interventional

Enrollment (Actual)

474

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France, 69317
        • Hopital croix rousse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Adult patients aged 18 years or more, both gender
  2. Receiving endotracheal intubation and mechanical ventilation for less than 36 hours
  3. Presenting with a Severe ARDS :

    • Acute onset
    • PaO2/FiO2 ≤ 200 (≤ 26.7 kPa)
    • Bilateral pulmonary infiltrates on frontal chest radiography
    • Capillary wedge pressure < 18 mm Hg if measured or no evidence for left atrial hypertension
  4. During since 12-24 hours
  5. AND with severity criteria : PaO2/FiO2 < 150 mm Hg (< 20 kPa) under FiO2 ≥ 0.6, PEEP ≥ 5 cm H2O and a tidal volume equal to 6 ml/kg PBW.
  6. Written consent from patient's next of kin

Exclusion Criteria:

  1. contra-indication to the prone position

    • Intracranial pressure > 30 mm Hg or cerebral perfusion pressure < 60 mm Hg
    • Massive haemoptysis needing urgent surgical or radiological treatment
    • Tracheal or thoracic surgery in the last 15 days
    • Facial trauma or surgery in the last 15 days
    • Deep venous thrombosis or pulmonary embolism treated in the last 2 days
    • Cardiac pace maker implantation in the last 2 days
    • Unstable bone dislocations of rachis, femur, rib cage, pelvis
    • Mean systolic arterial pressure less than 70 mm Hg despite vasopressive therapy
    • Pregnancy
    • Bronchopleural fistula treated with a single anterior chest tube (risk of kinking in prone position)
  2. Exclusion criteria for respiratory raisons

    • Necessity to use NOi or almitrine
    • Extra body circulation for oxygenation and/or CO2 epuration
  3. Exclusion criteria linked to clinical context

    • Pulmonary transplantation
    • Burns ≥ 20% of body surface
    • Chronic respiratory insufficiency under home oxygen therapy or non invasive ventilation
    • Chronic disease supposed to be fatal in less than 1 year
    • Non invasive ventilation for more than 24 hours before enrollment
  4. Other exclusion criteria

    • Decision to stop life-supportive therapies before enrollment
    • Enrollment in an other trial testing an intervention and with mortality as primary end point in the last 30 days
    • Prior enrollment in the same study
    • Prone position before enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A
prone position for at least 16 hours per day
prone position for at least 16 hours per day
No Intervention: B
semi-recumbent position

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
28-day mortality from all causes
Time Frame: 28 days
28 days

Secondary Outcome Measures

Outcome Measure
Time Frame
90-day mortality from all causes and incidence of ventilator-acquired pneumonia (VAP).
Time Frame: 90 days
90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guerin Claude, MD, Hospices Civils de Lyon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2008

Primary Completion (Actual)

August 1, 2011

Study Completion (Actual)

November 1, 2011

Study Registration Dates

First Submitted

September 10, 2007

First Submitted That Met QC Criteria

September 10, 2007

First Posted (Estimated)

September 11, 2007

Study Record Updates

Last Update Posted (Estimated)

December 19, 2025

Last Update Submitted That Met QC Criteria

December 13, 2025

Last Verified

December 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe